Clinical Trials Directory

Trials / Unknown

UnknownNCT04117061

Optimizing the Diagnosis of Acute Appendicitis

Optimizing the Diagnosis of Acute Appendicitis - Open, Randomized, Parallel Groups, Prospective Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Vilnius University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Aim of the study: to identify the signs of acute appendicitis delta signs - clinical, laboratory or ultrasound signs, whose change (delta) would allow to identify or deny the diagnosis of acute appendicitis without a computed tomography examination and thus to lower computed tomography rates.

Detailed description

This study consists of two parts: * In the first part investigators enroll all patients (except pregnant) that are refered to Vilnius University Hospital Santaros clinics with suspected acute appendicitis in order to get cohort data. All patient get primary clinical evaluation, laboratory tests (WBC, CRP) an ultrasound examination. * After primary evaluation if final diagnosis could not be made, and investigator still suspect acute appendicitis, participant is included in to randomised study part. * Randomised sudy part has two arms: control and observation groups. * Control group get the traditional diagnostic path - is refered to CT scan examination. * Observation group get repeated evaluation after 8-12 hours and only than is diagnosis stays unclear, patient gets a CT scan. * All patient are contacted after 30 days after visit to our hospital, to get information about their health status and possible additional visits to other hospitals or operations.

Conditions

Interventions

TypeNameDescription
PROCEDUREObservationPatient after primary investigation is observed for 8-12 hours, (instead of being send directly to CT scan), after observation repeated clinical evaluation, laboratory tests and ultrasound examination are done , if final diagnosis stays unclear the patient is refered to CT scan.

Timeline

Start date
2018-12-01
Primary completion
2021-01-01
Completion
2021-05-01
First posted
2019-10-07
Last updated
2019-10-07

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT04117061. Inclusion in this directory is not an endorsement.